Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer

Drug Safety

Volumn 30, Issue 8, 2007, Pages 715-726

  Matsushita, Yasuyuki ^a,b   Kuroda, Yasufumi ^b   Niwa, Shinpei ^b   Sonehara, Satoshi ^b   Hamada, Chikuma ^a   Yoshimura, Isao ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BAYESIAN CONFIDENCE PROPAGATION NEURAL NETWORK; COMPARATIVE STUDY; CRITERION VARIABLE; DATA BASE; DRUG INDUSTRY; EVALUATION; MULTI ITEM GAMMA POISSON SHRINKER; PRIORITY JOURNAL; PROPORTIONAL REPORTING RATIO; ROC CURVE; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; SIMULATION; STATISTICAL ANALYSIS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; COMPUTER SIMULATION; DRUG INDUSTRY; HUMANS; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS;

EID: 34548081712     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200730080-00008     Document Type: Article

References (20)

1. ICH-E2D-Expert Working Group. Post-approval safety data management: definitions and standards for expedited reporting [online]. Available from URL: http://www.ich.org/LOB/media/IA 631.pdf [Accessed 2006 Jul 28]
2. Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf 1994; 10 (2): 93-102
3. Lindquist M, Edwards IR, Bate A, et al. From association to alert: a revised approach to international signal analysis. Pharmacoepidemiol Drug Saf 1999; 8: S15-25
4. Evans SJW, Waller P, Davis S. Proportional reporting ratios: the uses of epidemiological methods of signal generation. Pharmacoepidemiol Drug Saf 1998; 7: S102
5. Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf 2002; 25 (6): 381-92
6. Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998; 54: 315-21
7. van Puijenbroek EP, Bate A, Leufkens HGM, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 3-10
8. Kubota K, Koide D, Hirai T. Comparison of data mining methodologies using Japanese spontaneous reports. Pharmacoepidemiol Drug Saf 2004; 13: 387-94
9. Stahl M, Lindquist M, Edwards IR, et al. Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database. Pharmacoipidemiol Drug Saf 2004; 13: 355-63
10. Follmann M, Michel A, Geyer C. Comparison of different methods for signal detection in the drug-safety database of a pharmaceutical company. In: the 20th International Conference of Pharmacoepidemiology (ICPE) & Therapeutic Risk Management; 2004 Aug 22-4; Bordeaux. Pharmacoepidemiol Drug Saf 2004; 13: S111
11. Roux E, Thiessard F, Fourrier-Reglat A, et al. Evaluation of Statistical Association Measures for the Automatic Signal Generation in Pharmacovigilance. IEEE Trans Inf Technol Biomed 2005; 9 (4): 518-27
12. Almenoff J, Tonning JM, Gould AL, et al. Perspectives on the use of data mining in pharmacovigilance. Drug Saf 2005; 28 (11): 981-1007
13. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Statist 1999; 53 (3): 177-202
14. DuMouchel W, Pregibon D. Empirical bayes screening for multi-item associations. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; 2001 Aug 26-9; San Francisco, 67-76
15. Lawson DH, O'Connor PC, Jick H. Drug attributed alterations in potassium handling in congestive cardiac failure. Eur J Clin Pharmacol 1982; 23: 21-5
16. Evans SJW. Statistics: analysis and presentation of safety data. In: Talbot J, Waller P, editors. Stephens' detection of new adverse drug reactions. 5th ed. West Sussex: Wiley, 2004: 316-25
17. ICH-E2E-Expert Working Group. Pharmacovigilance planning [online]. Available from URL: http://www.ich.org/LOB/media/MEDIA 1195.pdf [Accessed 2007 Jan 11]
18. Waller P, Heeley E, Moseley J. Impact analysis of signal detected from spontaneous adverse drug reaction reporting data. Drug Saf 2005; 28 (10): 843-50
19. Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29 (5): 385-96
20. Weber JCP. Epidemiology of adverse reactions to non-steroidal antiinflammatory drugs. Adv Inflam Res 1984; 6: 1-7